Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Surfactant protein B
(
SP-B
) is a 79-amino acid hydrophobic surfactant protein that plays a critical role in postnatal lung function. Homozygous
SP-B
(-/-)-deficient mice die of respiratory failure at birth, associated with severe pulmonary dysfunction and atelectasis. Heterozygous
SP-B
(+/-)-deficient mice have 50% less
SP-B
protein, proprotein, and
SP-B
mRNA compared with control mice and are highly susceptible to oxygen-induced lung injury. In the current study, we tested whether the susceptibility of
SP-B
(+/-) mice to
hyperoxia
was restored by intratracheal administration of exogenous
SP-B
. After exposure to 95% oxygen for 3 d, opening pressures were increased and maximal lung volumes were significantly decreased in
SP-B
(+/-) mice compared with
SP-B
(+/+) mice.
SP-B
(+/-) mice were administered purified bovine
SP-B
(2%) with DL-alpha dipalmitoyl phosphatidylcholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-( -glycerol)] (POPG) phospholipids or DPPC and POPG phospholipids intratracheally and exposed to 95% oxygen.
SP-B
-treated
SP-B
(+/-) mice survived longer in 95% oxygen. Although decreased lung function in
SP-B
(+/-) mice exposed to oxygen was not altered by administration of DPPC and POPG, administration of lipids containing 2% purified bovine
SP-B
restored lung function when assessed after 3 d in oxygen. Abnormalities in pulmonary function in
SP-B
(+/-) mice after oxygen exposure were associated with increased alveolar capillary leak, which was corrected by administration of
SP-B
with DPPC and POPG. Likewise, histologic abnormalities caused by oxygen-induced lung injury were improved by administration of
SP-B
with DPPC and POPG. Administration of phospholipids with the active
SP-B
peptide was sufficient to restore pulmonary function and prevent alveolar capillary leak after oxygen exposure, demonstrating the protective role of
SP-B
during oxygen-induced lung injury.
...
PMID:Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice. 1059 28
Surfactant protein B
(
SP-B
) is known to promote surfactant phospholipid film formation and reduce surface tension. Native
SP-B
is a homodimer in which subunit association is stabilized via covalent linkage through cysteine 48. We hypothesized that loss of the intersubunit bridge would alter
SP-B
function and lead to increased inflammation in response to challenge by
hyperoxia
or endotoxin. Transgenic mice in which
SP-B
cysteine 48 was mutated to serine were generated and crossed into the
SP-B
(-/-) background. Wild-type mice and transgenic mice carrying a single copy (SP-Bmon(+)) or two copies (SP-Bmon(++)) of the transgene were exposed to 95% O2 for 3 days or intratracheally injected with 10 microg of endotoxin. Interleukin-1beta, major intrinsic protein 2, and interleukin-6 in lung homogenates after 3 days of
hyperoxia
were significantly higher (P < 0.001) in SP-Bmon(+) mice than SP-Bmon(++) or wild-type mice. At 16 h after endotoxin injection, cytokines in lung tissues were higher in SP-Bmon(+) mice compared with wild-type mice (P < 0.05). Consistent with prolonged recovery in SP-Bmon(+) mice, the percentage of apoptotic cells in alveolar lavage was significantly lower in SP-Bmon(+) mice than in SP-Bmon(++) and wild-type mice. Overall, increased inflammation in SP-Bmon(+) mice was corrected to a large extent by increased gene dosage, indicating that formation of the intersubunit disulfide bridge is not critical for
SP-B
function.
...
PMID:Intersubunit disulfide bridge is not required for the protective role of SP-B against lung inflammation. 1213 57